Sort   by:  
 Page size 
UnknownA four-stage model for murine natural killer cell development in vivo.
Not available
S-EPMC8935775 | biostudies-literature
UnknownAn Oncolytic Virus Expressing IL15/IL15Rα Combined with Off-the-Shelf EGFR-CAR NK Cells Targets Glioblastoma.
Not available
S-EPMC8562586 | biostudies-literature
UnknownHijacking TYRO3 from Tumor Cells via Trogocytosis Enhances NK-cell Effector Functions and Proliferation.
Not available
S-EPMC8562593 | biostudies-literature
UnknownThe Mechanism of Anti-PD-L1 Antibody Efficacy against PD-L1-Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic Effector.
Not available
S-EPMC7253691 | biostudies-literature
UnknownChimeric antigen receptor-engineered natural killer cells for cancer immunotherapy.
Not available
S-EPMC7720606 | biostudies-literature
UnknownSpecific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunity.
Not available
S-EPMC10150871 | biostudies-literature
UnknownThe IL-15-AKT-XBP1s signaling pathway contributes to effector functions and survival in human NK cells.
Not available
S-EPMC6293989 | biostudies-literature
UnknownPDGF-D-PDGFRβ signaling enhances IL-15-mediated human natural killer cell survival.
Not available
S-EPMC8784126 | biostudies-literature
UnknownOff-the-shelf CAR natural killer cells secreting IL-15 target spike in treating COVID-19.
Not available
S-EPMC9095674 | biostudies-literature
UnknownAn oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma.
Not available
S-EPMC8501058 | biostudies-literature
Sort   by:  
 Page size